Mettler-Toledo International Inc.
NYSE:MTDMedical - Diagnostics & Research
+$16.60 today
- Market cap
- $34.55B
- Beta
- 1.26
- P/E (TTM)
- 26.6
- EPS (TTM)
- $43.14
Volume 0.16M
Average 0.19M
MTD Other Financing Activities
Financing cash flows not reported separately.
Mettler-Toledo International Inc.NYSE: MTD
Other Financing Activities · Q2 FY2026 · quarter ended Jun 2026
Other financing activities growth accelerates
Q2 FY2026 other financing activities of $7.89M (cash outflow) rose 4958.3% year over year, ahead of the -528.2% change in trailing-twelve-month other financing activities. Sequentially, it rose 260.3% from the prior quarter.
Context
- Other financing activities amounted to 0.2% of revenue in FY2025, down 0.1 pp from a year earlier.
- Other financing activities increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +4958.3% holds above the trailing-twelve-month pace of -528.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Financing Activities history
USD · from the cash flow
- Latest · FY2025
- (8.91M) USD
- Year-over-year change
- -169.9%
| Period | Period end | Other Financing Activities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (8.91M) | -169.9% |
| FY2024 | 2024-12-31 | 12.75M | +19.8% |
| FY2023 | 2023-12-31 | 10.64M | -55.8% |
| FY2022 | 2022-12-31 | 24.1M | +37.9% |
| FY2021 | 2021-12-31 | 17.48M | — |
Other Financing Activities vs competitors
How MTD compares with its peers on the latest reported figures
- MTD's LTM Jun 2026 other financing activities of $18.07M is the 9th largest of the 10 companies compared; the peer median is $2.21M.
- Its year-over-year change of -528.2% is the 8th highest of 10, against a peer median of +844.4%.
- Other financing activities amounts to 0.4% of revenue for MTD, versus a peer median of 2.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $4.77B | +1086.5% | — | 10.1% | |
| LTM Sep 2026 | $1.96B | +265.7% | +9.6% | 7.6% | |
| LTM Jun 2026 | $670.1M | +4508.6% | -10.2% | 19.1% | |
| LTM Jul 2026 | $129.32M | -753.3% | — | 2.8% | |
| LTM Jun 2026 | $103.3M | +4404.2% | -23.7% | 2.9% | |
| LTM Sep 2026 | $55.3M | +6812.5% | — | 0.8% | |
| LTM Jul 2026 | $42M | -625.0% | — | 0.6% | |
| LTM Oct 2026 | $22.29M | +90.1% | -42.5% | 2.1% | |
| LTM Jun 2026 | $18.07M | -528.2% | — | 0.4% | |
| LTM Jul 2026 | $2.21M | +844.4% | +71.0% | 0.1% | |
| Peer median (excluding MTD) | $2.21M | +844.4% | -10.2% | 2.8% | |
Competitors are the stored peer set for MTD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 768.99M | 872.5M | 788.78M | 863.14M | 869.19M |
| Depreciation & Amortization | 108.06M | 113.02M | 121.16M | 123.22M | 125.61M |
| Deferred Income Tax | 563K | 26.52M | (13.37M) | (28.2M) | 3.79M |
| Stock-Based Compensation | 19.6M | 19.66M | 17.93M | 19.98M | 22.51M |
| Change in Working Capital | 4.4M | (172.64M) | 51.38M | (9.8M) | (65.33M) |
| Accounts Receivables | (66.47M) | (83.42M) | 50.3M | (53M) | (46.35M) |
| Inventory | (118.72M) | (43.39M) | 71.02M | 24.13M | (7.65M) |
| Accounts Payables | 93.97M | (13.83M) | (40.55M) | 12.08M | 33.76M |
| Other Working Capital | 95.61M | (32M) | (29.39M) | 6.99M | (45.09M) |
| Other Non-Cash Items | 7.23M | 0 | 0 | 0 | 0 |
| Operating Cash Flow | 908.83M | 859.07M | 965.87M | 968.35M | 955.77M |
| Capital Expenditures | (107.58M) | (121.24M) | (105.32M) | (103.9M) | (107.12M) |
| Acquisitions (Net) | (220.86M) | (37.95M) | (5.81M) | (10.09M) | (93.84M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 14.33M | 19.8M | (20.56M) | (5.47M) | 7.09M |
| Investing Cash Flow | (314.11M) | (139.4M) | (131.69M) | (119.46M) | (193.87M) |
| Debt Repayment | 391.97M | 359.86M | 29.77M | (18.73M) | 21.46M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 32.27M |
| Common Stock Repurchased | (1,000M) | (1.1B) | (900M) | (850M) | (800M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 17.48M | 24.1M | 10.64M | 12.75M | (8.91M) |
| Financing Cash Flow | (590.55M) | (716.04M) | (859.59M) | (855.98M) | (755.17M) |
| Effect of Forex Changes | 142K | (6.23M) | (754K) | (3.35M) | 801K |
| Net Change in Cash | 4.31M | (2.6M) | (26.16M) | (10.45M) | 7.53M |
| Free Cash Flow | 801.25M | 737.83M | 860.55M | 864.45M | 848.65M |
Mettler-Toledo International Inc.
NYSE:MTD
Intrinsic Alpha fair value
Locked
Current Price
$1,737.26
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.